Bill · H.R. 10569· House(119-HR-10569)
Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act
- Introduced
- 9/24/2026
- Last activity
- 9/24/2026 — Referred to the House Committee on Homeland Security.
- Sponsored by
- Ro Khanna
- Cosponsors
- - 1 - 1
- Introduced
- In Committee
What this bill would do
This bill is known as the Protecting Biotechnology and Biomanufacturing as Critical Infrastructure Act. It amends the Homeland Security Act of 2002 to give the Cybersecurity and Infrastructure Security Agency (CISA) specific duties regarding the protection of biotechnology and biomanufacturing infrastructure. The legislation directs CISA to provide technical assistance, perform analyses, and engage with owners and operators in this field. It also requires assessments and a comprehensive national plan that includes biotechnology and biomanufacturing. Additionally, the bill mandates that the Director of CISA submit a work plan, an implementation report, and a report on emerging biotechnology to specific congressional committees.
Yes· 3 of 8
Does this better protect the country from computer attacks?+5
The legislation tasks CISA with protecting biotechnology and biomanufacturing infrastructure, enhancing cybersecurity and physical security coordination.
Does this make what the government does easier for the public to see?+3
The legislation mandates work plans, implementation reports, and updates submitted to congressional committees, increasing accountability.
Would business owners be better off under this?+3
Biotechnology and biomanufacturing business owners benefit from specialized CISA technical assistance and structured security coordination.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Section 2(a) amends Section 2202(c)(5) of the Homeland Security Act to designate agency staff to provide analyses, expertise, and technical assistance for critical infrastructure with no designated Sector-Specific Agency, which includes biotechnology and biomanufacturing infrastructure. This could benefit the industry by providing specialized government support to keep these systems secure.
-
Section 2(a) amends Section 2202(e)(1)(B) to require that security assessments for infrastructure without a designated Sector-Specific Agency be carried out in coordination with existing groups like BIO-ISAC, H-ISAC, and industry member associations. This is a positive step because it relies on collaboration with groups already working within these fields.
-
Section 2(b) requires the Director of CISA to submit a clear work plan, an implementation report, and a report on emerging biotechnology to Congress within specific timelines. Holding officials accountable through mandatory reporting ensures that Congress can track progress on protecting this vital infrastructure.
Potential Negative Impacts for People
- Based strictly on the provided text, there are no specific negative impacts, burdens, or consequences explicitly identified for individuals or groups of people in the United States.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Governance And Ideology
- Improves Government Transparency+3Increases Federal Power+2
- National Security And Foreign Policy
- Improves Cybersecurity Defense+5
- Demographic And Interest Groups
- Good For Business Owners+3Good For Students+1
- Economy And Finance
- Improves Small Business Support+3
- Education And Technology
- Increases Scientific Research Funding+2
- Healthcare
- Increases Research Funding+2
- 9/24/2026
- Referred to the House Committee on Homeland Security.
- 2 Cosponsors added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Stephanie BiceRepublican · Oklahoma
Scott PetersDemocrat · California